RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 42 filers reported holding RENEO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $246,101 | +4.9% | 32,318 | -9.6% | 0.00% | – |
| Q2 2023 | $234,592 | -7.3% | 35,761 | -15.5% | 0.00% | – |
| Q1 2023 | $253,127 | +174.6% | 42,329 | +7.0% | 0.00% | – |
| Q4 2022 | $92,196 | -31.2% | 39,569 | -0.8% | 0.00% | – |
| Q3 2022 | $134,000 | +148.1% | 39,886 | +94.6% | 0.00% | – |
| Q2 2022 | $54,000 | +237.5% | 20,495 | +278.9% | 0.00% | – |
| Q1 2022 | $16,000 | -73.8% | 5,409 | -24.3% | 0.00% | – |
| Q4 2021 | $61,000 | +103.3% | 7,148 | +71.8% | 0.00% | – |
| Q3 2021 | $30,000 | -89.7% | 4,160 | -86.7% | 0.00% | – |
| Q2 2021 | $291,000 | – | 31,190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $7,083,000 | 7.27% |
| Abingworth LLP | 2,073,957 | $6,077,000 | 1.72% |
| Aisling Capital Management LP | 886,075 | $2,605,000 | 1.41% |
| Novo Holdings A/S | 3,430,377 | $10,085,000 | 0.53% |
| NEA Management Company, LLC | 4,786,921 | $14,073,000 | 0.41% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 700,000 | $2,058,000 | 0.12% |
| Rock Springs Capital Management LP | 1,143,185 | $3,361,000 | 0.08% |
| Ikarian Capital, LLC | 185,597 | $546,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 100,000 | $294,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 17,648 | $52,000 | 0.00% |